Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-000242
Filing Date
2025-01-03
Accepted
2025-01-03 12:55:09
Documents
2
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 2075
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 2989
  Complete submission text file 0001127602-25-000242.txt   6702
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EMERSON ELECTRIC CO. 8000 W. FLORISSANT AVENUE ST. LOUIS MO 63136
Business Address
Karsanbhai Surendralal Lanca (Reporting) CIK: 0001754881 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 25504902